StartUp Health July 30, 2024
RetiSpec’s $10M Series A financing will enable the StartUp Health company to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer’s disease.
RetiSpec, a Toronto, ON-based innovator in AI-driven eye diagnostics for brain health and a member of the StartUp Health Alzheimer’s Moonshot Community, raised $10M led by iGan Partners, with participation from Eli Lilly and Company, Topcon Healthcare, Gentex Corporation, the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator, Verge HealthTech Fund, University of Minnesota’s Discovery Capital, Ontario Brain Institute, Centre for Aging + Brain Health Innovation, and private investors. source>
This week’s reported health innovation funding also included:
Kestra Medical Technologies, a Kirkland, WA-based wearable medical device and digital healthcare company focused on cardiac patients, raised...
Today's Sponsors
Today's Sponsor